Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer

Enrolling by invitation · Phase 1

Conditions studied: Prostate Cancer, Radical Prostatectomy

In brief

In this research study, is assessing the feasibility of using an MR-guided implantable microdevice to measure tumor response to chemotherapy and other clinically relevant drugs in participants that have prostate cancer and are scheduled for a radical prostatectomy. The name of the study intervention involved in this study is: \- Implantation of a MR-guided microdevice

Key facts

Study ID
NCT04399876
Run by
Brigham and Women's Hospital
People needed
35
Starts
2020-06-22
Expected to finish
2027-11-01
Last updated by the study team
2026-05-18

Who can join

Age: 22 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.